BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters

"We are thrilled to have agreed to extend our partnership with BD and can't think of a better organization to partner with in this area. Having been partners since 1994, we know each other well and share common values with a commitment to help patients in need and not least, make the world a healthier place. Today's announcement also supports our strategy of focusing on our licensing business, so it is an important first step on our transformation while we also ensure a smooth transition for the benefit of patients", states Thomas von Koch, CEO of Bactiguard. 

"We are thrilled to have agreed to extend our partnership with BD and can't think of a better organization to partner with in this area. Having been partners since 1994, we know each other well and share common values with a commitment to help patients in need and not least, make the world a healthier place. Today's announcement also supports our strategy of focusing on our licensing business, so it is an important first step on our transformation while we also ensure a smooth transition for the benefit of patients", states Thomas von Koch, CEO of Bactiguard. 

The impact of the extended partnership with BD is expected to have a limited but positive effect on Bactiguard's income statement for 2024. 

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, 2023-12-14 at 09:30 CET. 

CONTACT:

For further information, please contact:
Patrick Bach, CFO +46 761 295 911 
Nina Nornholm, Head of Communication & IR +46 708 550 356 

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/bd-to-become-exclusive-global-license-partner-excluding-china-for-bactiguard-coated-foley-catheters-302015260.html